Internal Medicine Alert – March 30, 2003
March 30, 2003
View Issues
-
Fat City
The metabolic syndrome affects more than 1 in 5 Americans and is increased substantially in Mexican Americans and by several modifiable lifestyle factors. -
Outcomes with Angiotensin-Converting Enzyme Inhibitors and Diuretics for Hypertension in the Elderly
Initiation of antihypertensive treatment involving ACE inhibitors in older subjects, particularly men, appears to lead to better outcomes than treatment with diuretic agents, despite similar reductions of blood pressure. -
To Drink or Not to Drink? That is the Question!
A randomized, diet-controlled interventional study demonstrates that moderate alcohol consumption reduces plasma C-reactive protein and fibrinogen levels. -
Vitamin A and Fracture Risk
The findings of this study, which are consistent with the results of studies in animals, as well as in vitro and epidemiologic dietary studies, suggest that current levels of vitamin A supplementation and food fortification in many Western countries may need to be reassessed. -
Pharmacology Update: Eletriptan Hydrochloride (Relpax — Pfizer)
Eletriptan is the newest triptan to be approved for the treatment of migraine headaches. It marks the seventh entry into this crowded market. -
Clinical Briefs
Use of Hip Protectors in Nursing Homes: Cluster Randomized Controlled Trial; Disclosing Unanticipated Outcomes and Medical Errors; Non-Invasive Positive Pressure Ventilation to Treat Respiratory Failure Resulting from Exacerbations of COPD